COMMUNIQUÉS West-GlobeNewswire

-
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed to Address Immune Dysfunction
06/03/2024 -
Zenas BioPharma Appoints Patricia Allen to its Board of Directors
06/03/2024 -
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
06/03/2024 -
CB Insights Ranks Verana Health as a Leader in EHR-based Patient Recruitment Market
06/03/2024 -
Auron Announces Poster Presentations at 2024 AACR Annual Meeting
06/03/2024 -
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers
06/03/2024 -
Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference
06/03/2024 -
Avalyn to Participate in Leerink Partners Global Biopharma Conference
06/03/2024 -
Araris Biotech AG to Present Data on Antibody-Drug Conjugate Candidates at American Association for Cancer Research (AACR) Annual Meeting 2024
06/03/2024 -
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
06/03/2024 -
Syncromune® Inc. to Present Initial Clinical Data from SYNC-T™ SV-102 Phase 1 as a Late-Breaker at the American Association for Cancer Research Annual Meeting 2024
06/03/2024 -
Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
06/03/2024 -
Frontier Medicines to Present Preclinical Data at the American Association for Cancer Research Annual Meeting 2024
06/03/2024 -
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
06/03/2024 -
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
06/03/2024 -
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
06/03/2024 -
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
06/03/2024 -
Kraig Biocraft Laboratories Preparing Additional Business Investment License to Advance its Business Operations
06/03/2024 -
Kamada Issues 2024 CEO Letter to Shareholders
06/03/2024
Pages